Department of Medicine, Dumfries and Galloway Royal Infirmary, Dumfriesshire, UK.
Postgrad Med J. 2012 May;88(1039):255-60. doi: 10.1136/postgradmedj-2011-130243. Epub 2012 Feb 23.
Current recommendations for the treatment of vitamin D deficiency vary from calciferol 800 IU per day to loading doses of vitamin D followed by maintenance therapy of up to 2000 IU per day.
To assess the preparations and doses of vitamin D used to load and maintain patients with serum 25-hydroxyvitamin D (25OHD) <25 nmol/l.
We examined all requests for serum 25OHD over a 12-month period, from September 2009 to 2010 in southwest Scotland. We wrote to all 33 general practices asking whether they usually started replacement therapy with a loading dose and/or recommended over-the-counter maintenance preparations. We accessed the Emergency Care Summary for all patients with serum 25OHD <25 nmol/l to determine whether they had been prescribed maintenance therapy.
Serum 25OHD was requested in 1162 patients. Levels were <25 nmol/l in 282 (24%) patients, only 173 (61%) of whom were receiving vitamin D replacement therapy 3-15 months after diagnosis. Only four (1.4%) were prescribed a loading dose. One hundred and fifty-three (54%) were treated with cholecalciferol or ergocalciferol and 19 (7%) with alfacalcidol or calcitriol. The median dose of chole/ergocalciferol was 800 IU per day, usually in combination with 1200 mg calcium per day.
We have shown a divergence between clinical practice and even the most conservative expert advice for vitamin D replacement therapy. Possible explanations are conflicting advice on treatment and difficulty obtaining suitable vitamin D preparations, particularly high dose vitamin D and vitamin D without calcium, in the UK.
目前,维生素 D 缺乏症的治疗建议从每天 800IU 的钙三醇到维生素 D 的负荷剂量,再到每天 2000IU 的维持治疗不等。
评估用于负荷和维持血清 25-羟维生素 D(25OHD)<25nmol/L 的患者的维生素 D 制剂和剂量。
我们检查了 2009 年 9 月至 2010 年 12 个月期间苏格兰西南部所有请求检测血清 25OHD 的记录。我们写信给所有 33 家全科医生,询问他们是否通常开始使用负荷剂量进行替代治疗,以及是否推荐非处方维持制剂。我们查阅了所有血清 25OHD<25nmol/L 的患者的急诊护理总结,以确定他们是否接受了维持治疗。
有 1162 名患者请求检测血清 25OHD。282 名(24%)患者的血清 25OHD 水平<25nmol/L,只有 173 名(61%)患者在诊断后 3-15 个月接受了维生素 D 替代治疗。只有 4 名(1.4%)患者接受了负荷剂量。153 名(54%)患者接受了胆钙化醇或麦角钙化醇治疗,19 名(7%)患者接受了阿尔法骨化醇或骨化三醇治疗。胆钙化醇/麦角钙化醇的中位剂量为每天 800IU,通常与每天 1200mg 钙联合使用。
我们发现,临床实践与维生素 D 替代治疗的最保守的专家建议之间存在差异。可能的解释是英国存在治疗建议相互矛盾,以及难以获得合适的维生素 D 制剂,尤其是高剂量维生素 D 和不含钙的维生素 D。